Daily News Podcast

Updated anthrax vaccine recommendations


 

The advisory committee on Immunization Practices voted to approve recommendations for the use of Anthrax Vaccine Adsorbed (AVA) in post-exposure prophylaxis (PEP) in the event of a wide-area release of Bacillus anthracis spores. Also today, the FDA approves topical anticholinergic for primary axillary hyperhidrosis, a shortage of ob.gyns. looms, and more Americans missed care in 2017 as a result of cost.

Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Impact of varicella vaccination on herpes zoster is not what was expected
MDedge Rheumatology
Canakinumab cut gout attacks in CANTOS
MDedge Rheumatology
Galectin-3: A post-MI prognostic biomarker for our times
MDedge Rheumatology
JAK inhibitor therapy promising for refractory dermatomyositis
MDedge Rheumatology
Patients going without as insulin prices skyrocket
MDedge Rheumatology
FDA approves Epidiolex for both Lennox-Gastaut syndrome and Dravet syndrome
MDedge Rheumatology
Opioids do more harm than good for musculoskeletal pain
MDedge Rheumatology
Adalimumab strikes out for aortic inflammation in psoriasis
MDedge Rheumatology
Addiction: Veterans with pain, opioid use disorder
MDedge Rheumatology
Medicare beneficiaries are dying differently
MDedge Rheumatology